The identity every market and product brand has to answer to.
Pharmaceutical corporate identity for the company-level brand: the identity that has to remain coherent across every market, every product line and every audience, from investors to regulators to the person reading a careers page.
A pharmaceutical corporate identity is read by an unusually wide range of audiences with different expectations: investors judging credibility, regulators expecting seriousness, patients wanting trustworthiness, candidates wanting a workplace. Few sectors ask one identity to do that much work.
Brand strategy grounded in that audience range, the visual identity system, comprehensive guidelines for a multi-market, multi-product organisation, and governance for how product and affiliate brands relate to it.
We take the strategy and positioning your leadership defines and translate it into a coherent visual and verbal identity. The identity work stays grounded in decisions your leadership owns, not ours.
The scale our pharmaceutical corporate identity work has operated at.
The tension the identity has to resolve differs by company structure. Pharmaceutical corporate identity starts there.
What comes up before a corporate identity project.
Scope and audience are the difference. Corporate identity represents the whole company to investors, regulators, patients and candidates at once, while a product identity speaks to one therapeutic area or drug. See brand identity for that narrower, product-level version and how it sits inside the corporate system.
No, positioning is a leadership decision, not one we make on your behalf. We translate the positioning your leadership defines into a coherent visual and verbal identity, and we can facilitate that strategic conversation directly if it has not yet happened before the identity work begins.
Within governance we define together, yes. Some elements typically stay fixed across the whole group while others allow local adaptation for market or regulatory reasons, and making that boundary explicit in writing is part of the guidelines work rather than left to individual affiliate judgment.
Less often than most sectors expect. A corporate identity built for durability from the start should not need a reactive refresh for years, and that longevity requirement is itself part of the brief we design against, not an incidental benefit of a good outcome that only shows up later.
Corporate identity work pairs with rebrand rollout and naming. These are the related services.
A company that has outgrown its current identity, or one that has never had one properly defined. Tell us your structure and we will tell you how we would approach the pharmaceutical corporate identity.